Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death

Vista sencilla de ítem
dc.contributor.authorMartínez, Pablo
dc.contributor.authorSilva, Mónica
dc.contributor.authorAbarzúa, Sebastián
dc.contributor.authorTevy, María Florencia
dc.contributor.authorJaimovich, Enrique
dc.contributor.authorConstantine-Paton, Martha
dc.contributor.authorBustos, Fernando J.
dc.contributor.authorvan Zundert, Brigitte
dc.date.accessioned2025-04-08T14:29:04Z
dc.date.available2025-04-08T14:29:04Z
dc.date.issued2024-12
dc.descriptionIndexación (Scopus)
dc.description.abstractAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of motoneurons (MNs), and despite progress, there is no effective treatment. A large body of evidence shows that astrocytes expressing ALS-linked mutant proteins cause non-cell autonomous toxicity of MNs. Although MNs innervate muscle fibers and ALS is characterized by the early disruption of the neuromuscular junction (NMJ) and axon degeneration, there are controversies about whether muscle contributes to non-cell-autonomous toxicity to MNs. In this study, we generated primary skeletal myotubes from myoblasts derived from ALS mice expressing human mutant SOD1G93A (termed hereafter mutSOD1). Characterization revealed that mutSOD1 skeletal myotubes display intrinsic phenotypic and functional differences compared to control myotubes generated from non-transgenic (NTg) littermates. Next, we analyzed whether ALS myotubes exert non-cell-autonomous toxicity to MNs. We report that conditioned media from mutSOD1 myotubes (mutSOD1-MCM), but not from control myotubes (NTg-MCM), induced robust death of primary MNs in mixed spinal cord cultures and compartmentalized microfluidic chambers. Our study further revealed that applying mutSOD1-MCM to the MN axonal side in microfluidic devices rapidly reduces mitochondrial axonal transport while increasing Ca2 + transients and reactive oxygen species (i.e., H2O2). These results indicate that soluble factor(s) released by mutSOD1 myotubes cause MN axonopathy that leads to lethal pathogenic changes.
dc.description.urihttps://link.springer.com/article/10.1186/s10020-024-00942-4?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=scopus
dc.identifier.citationMolecular Medicine Volume 30, Issue 1 December 2024 Article number 185
dc.identifier.doi10.1186/s10020-024-00942-4
dc.identifier.issn1076-1551
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/64017
dc.language.isoen_US
dc.publisherBioMed Central Ltd
dc.rights.licenseAtribución/Reconocimiento 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectALS
dc.subjectAxonopathy
dc.subjectMitochondria
dc.subjectALS
dc.subjectAxonopathy
dc.subjectMitochondria
dc.subjectMotoneuron
dc.subjectMuscle
dc.subjectMyotubes
dc.subjectPathology
dc.titleSkeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Skeletal-myotubes-expressing-ALS-mutant-SOD1-induce-pathogenic-changes-impair-mitochondrial-axonal-transport-and-trigger-motoneuron-deathMolecular-Medicine.pdf
Tamaño:
5.8 MB
Formato:
Adobe Portable Document Format
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista